{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:14:23Z","timestamp":1771258463399,"version":"3.50.1"},"reference-count":35,"publisher":"Japan Neurosurgical Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.2176\/jns-nmc.2022-0359","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:35:52Z","timestamp":1695422152000},"page":"535-541","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of Changes in Intrathecal Baclofen Dosage over Time due to Causative Disease"],"prefix":"10.2176","volume":"63","author":[{"given":"Yuki","family":"KIMOTO","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"OSHINO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"TANI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"HOSOMI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Ming","family":"KHOO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"FUJITA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"MIURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamitsu","family":"IWATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"EMURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"MATSUHASHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"ONODA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"ISHIUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takufumi","family":"YANAGISAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"},{"name":"Institute for Advanced Co-Creation Studies, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"HIRATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"},{"name":"Department of Neurological Diagnosis and Restoration, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"KISHIMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","unstructured":"1) Lance JW: Spasticity: disordered motor control, year book medical, in Feldman RG, Young RR, Koella WP (eds): Symposium Synopsis. Chicago, 1980, pp 485-494"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bowery NG: GABAB receptor pharmacology. <i>Annu Rev Pharmacol Toxicol<\/i> 33: 109-147, 1993","DOI":"10.1146\/annurev.pa.33.040193.000545"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zieglg\u00e4nsberger W: Dorsal horn neuropharmacology: baclofen and morphine. <i>Ann N Y Acad Sci<\/i> 531: 150-156, 1988","DOI":"10.1111\/j.1749-6632.1988.tb31821.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gunnarsson S, Alehagen S, Lemming D, Ertzgaard P, Ghaderi Berntsson S, Samuelsson K: Experiences from intrathecal baclofen treatment based on medical records and patient- and proxy-reported outcome: a multicentre study. <i>Disabil Rehabil<\/i> 41: 1037-1043, 2019","DOI":"10.1080\/09638288.2017.1419291"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Walter M, Altermatt S, Furrer C, Meyer-Heim A: Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications. <i>Dev Neurorehabil<\/i> 17: 368-374, 2014","DOI":"10.3109\/17518423.2013.827256"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Clearfield JS, Nelson ME, McGuire J, Rein LE, Tarima S: Intrathecal Baclofen Dosing Regimens: A Retrospective Chart Review. <i>Neuromodulation<\/i> 19: 642-649, 2016","DOI":"10.1111\/ner.12361"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Borrini L, Bensmail D, Thiebaut JB, Hugeron C, Rech C, Jourdan C: Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults. <i>Arch Phys Med Rehabil<\/i> 95: 1032-1038, 2014","DOI":"10.1016\/j.apmr.2013.12.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Creamer M, Cloud G, Kossmehl P, et al.: Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). <i>J Neurol Neurosurg Psychiatry<\/i> 89: 642-650, 2018","DOI":"10.1136\/jnnp-2017-317021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Schiess MC, Eldabe S, Konrad P, et al.: Intrathecal Baclofen for Severe Spasticity: Longitudinal Data From the Product Surveillance Registry. <i>Neuromodulation<\/i> 23: 996-1002, 2020","DOI":"10.1111\/ner.13097"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chan DY, Chan SS, Chan EK, et al.: Blessing or burden? Long-term maintenance, complications and clinical outcome of intrathecal baclofen pumps. <i>Surg Pract<\/i> 22: 105-110, 2018","DOI":"10.1111\/1744-1633.12308"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mathur SN, Chu SK, McCormick Z, Chang Chien GC, Marciniak CM: Long-term intrathecal baclofen: outcomes after more than 10 years of treatment. <i>P.M.R<\/i> 6: 506-513.e1, 2014","DOI":"10.1016\/j.pmrj.2013.12.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G: A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. <i>Arch Phys Med Rehabil<\/i> 86: 2165-2171, 2005","DOI":"10.1016\/j.apmr.2005.05.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Pucks-Faes E, Dobesberger J, Hitzenberger G, et al.: Intrathecal Baclofen in Hereditary Spastic Paraparesis. <i>Front Neurol<\/i> 10: 901, 2019","DOI":"10.3389\/fneur.2019.00901"},{"key":"14","unstructured":"14) Ashworth B: Preliminary trial of carisoprodal in multiple sclerosis. <i>Practitioner<\/i> 192: 540-542, 1964"},{"key":"15","unstructured":"15) R Core Team. R: A language and Environment for Statistical Computing. R Foundation for Statistical Computing. https:\/\/www.R-project.org\/"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Surveillance of Cerebral Palsy in Europe: Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). <i>Dev Med Child Neurol<\/i> 42: 816-824, 2000","DOI":"10.1111\/j.1469-8749.2000.tb00695.x"},{"key":"17","unstructured":"17) Yamaguchi H, Kaku M, Tsuruya E, et al.: Drug Use Result Survey of Gabalon Intrathecal Injection (Baclofen) and SynchroMed Pump System -Final Report-. <i>Rinsho Iyaku<\/i> 32: 419-467, 2016 (Japanese)"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ochs G, Struppler A, Meyerson BA, et al.: Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. <i>J Neurol Neurosurg Psychiatry<\/i> 52: 933-939, 1989","DOI":"10.1136\/jnnp.52.8.933"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ordia JI, Fischer E, Adamski E, Spatz EL: Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. <i>J Neurosurg<\/i> 85: 452-457, 1996","DOI":"10.3171\/jns.1996.85.3.0452"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Dan B, Cheron G: Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: a case study. <i>Neurophysiol Clin<\/i> 30: 43-48, 2000","DOI":"10.1016\/S0987-7053(00)88866-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Molteni F, Carda S, Cazzaniga M, Magoni L, Rossini M, Caimmi M: Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study. <i>Am J Phys Med Rehabil<\/i> 84: 303-306, 2005","DOI":"10.1097\/01.PHM.0000156892.04239.B6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Heetla HW, Halbertsma JP, Dekker R, Staal MJ, van Laar T: Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report. <i>Arch Phys Med Rehabil<\/i> 96: 1166-1169, 2015","DOI":"10.1016\/j.apmr.2015.01.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dan B, Bouillot E, Bengoetxea A, Cheron G: Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis. <i>Neurosci Lett<\/i> 280: 175-178, 2000","DOI":"10.1016\/S0304-3940(00)00778-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Margetis K, Korfias S, Boutos N, et al.: Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia. <i>Clin Neurol Neurosurg<\/i> 123: 142-145, 2014","DOI":"10.1016\/j.clineuro.2014.05.024"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lambrecq V, Muller F, Joseph PA, Cuny E, Mazaux JM, Barat M: [Intrathecal baclofen in hereditary spastic paraparesis: benefits and limitations]. <i>Ann Readapt Med Phys<\/i> 50: 577-581, 2007 (French)","DOI":"10.1016\/j.annrmp.2007.02.009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hasnat MJ, Rice JE: Intrathecal baclofen for treating spasticity in children with cerebral palsy. <i>Cochrane Database Syst Rev<\/i> 2015: CD004552, 2015","DOI":"10.1002\/14651858.CD004552.pub2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kishima H, Yanagisawa T, Goto Y, et al.: Respiratory Function Under Intrathecal Baclofen Therapy in Patients With Spastic Tetraplegia. <i>Neuromodulation<\/i> 19: 650-654, 2016","DOI":"10.1111\/ner.12394"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) McCarty SF, Gaebler-Spira D, Harvey RL: Improvement of sleep apnea in a patient with cerebral palsy. <i>Am J Phys Med Rehabil<\/i> 80: 540-542, 2001","DOI":"10.1097\/00002060-200107000-00016"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Bensmail D, Quera Salva MA, Roche N, et al.: Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. <i>Neurology<\/i> 67: 1432-1436, 2006","DOI":"10.1212\/01.wnl.0000239827.38036.23"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) McIntyre A, Mays R, Mehta S, et al.: Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review. <i>J Spinal Cord Med<\/i> 37: 11-18, 2014","DOI":"10.1179\/2045772313Y.0000000102"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Marathe A, Allahabadi S, Abd-Elsayed A, et al.: Intrathecal Baclofen Monotherapy and Polyanalgesia for Treating Chronic Pain in Patients with Severe Spasticity. <i>Curr Pain Headache Rep<\/i> 25: 79, 2021","DOI":"10.1007\/s11916-021-00994-9"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kumru H, Benito-Penalva J, Kofler M, Vidal J: Analgesic effect of intrathecal baclofen bolus on neuropathic pain in spinal cord injury patients. <i>Brain Res Bull<\/i> 140: 205-211, 2018","DOI":"10.1016\/j.brainresbull.2018.05.013"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Motta F, Antonello CE: Comparison between an Ascenda and a silicone catheter in intrathecal baclofen therapy in pediatric patients: analysis of complications. <i>J Neurosurg Pediatr<\/i> 18: 493-498, 2016","DOI":"10.3171\/2016.4.PEDS15646"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Fjelstad AB, Hommelstad J, Sorteberg A: Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. <i>J Neurosurg Pediatr<\/i> 4: 487-493, 2009","DOI":"10.3171\/2009.6.PEDS0921"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Draulans N, Vermeersch K, Degraeuwe B, et al.: Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution. <i>Clin Rehabil<\/i> 27: 1137-1143, 2013","DOI":"10.1177\/0269215513488607"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/63\/12\/63_2022-0359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:31:30Z","timestamp":1715574690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/63\/12\/63_2022-0359\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2022-0359","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"article-number":"2022-0359"}}